Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.39 USD | -1.28% | +0.19% | -40.04% |
Jun. 05 | Aurinia Pharmaceuticals Inc. Presents Safety and Efficacy Profile of LUPKYNIS® for People with Lupus Nephritis | CI |
Jun. 03 | Lucien Selce Sends Letter to Aurinia shareholders | CI |
- Stock Market
- Equities
- AUPH Stock
- News Aurinia Pharmaceuticals Inc.